Nancy A. Dawson

Canadian Journal of Urology, Vol.10, No.6, pp. 2036-2037, 2003

Abstract A multidisciplinary approach to prostate cancer has become the rule and not the exception. Involving the entire team, which includes a medical oncologist, from the time of initial diagnosis is optimal. This facilitates maximal patient education regarding treatment options and enhances informed decision making.
A coordinated approach also promotes enrollment on clinical trials, which are often, multimodality, especially in high-risk early stage prostate cancer. Integrated therapeutic strategies throughout the patient's disease course can improve both patient care and satisfaction. More >

Andrew W. Bruce, Gregor Reid

Canadian Journal of Urology, Vol.10, No.2, pp. 1785-1789, 2003

Abstract Emerging from the stigma of once being referred to as “snake oil”, excellent scientific and clinical evidence now exists to indicate that probiotics do indeed have a role to play in medicine. The proper definition of probiotics is important “Live microorganisms which when administered in adequate amounts confer a health benefit on the host”, for several reasons. It rules out so-called probiotics that have no clinically proven, peer-reviewed data, and it states the need to have viable bacteria present, unlike these pseudo products which are often wrongly labeled, poorly manufactured, with low or no viability… More >

Vladimir Mouraviev, Martin E. Gleave

Canadian Journal of Urology, Vol.10, No.1, pp. 1737-1742, 2003

Abstract Objective: To review the careers of two urologists among Nobel Prize-winners in medicine, W. Forssmann and C.H. Huggins, and the significance of their contributions.
Material and methods: Investigation was performed based on analysis of collected findings from the biographies of laureates, their scientific publications and the Nobel archive database.
Results: Review revealed that of the 175 scientists and physicians who received the Nobel Prize, just over one half (94) held an MD degree while the remainder were PhD’s or other degrees. Of the 94 MD-degreed physicians nine (9.4%) were surgeons. Two of these laureates were urologists - Drs.… More >

Richard W. Casey

Canadian Journal of Urology, Vol.9, No.6, pp. 1681-1683, 2002

Abstract The recent interest in the potential applications of new testosterone preparations has stimulated industry and physicians to develop indications for their use. Despite little scientific evidence to support the widespread application of testosterone in aging men, a clinical symptom complex called Partial Androgen Deficiency in the Aging Male (PAD AM) has been described. Many of these symptoms can be successfully treated without testosterone administration. The author suggests that prospective randomized clinical trials are necessary to support the application of testosterone in the PADAM patient and until then physicians take a more balanced approach in this More >

Jeremy P. W. Heaton

Canadian Journal of Urology, Vol.9, No.6, pp. 1677-1680, 2002

Abstract Andropause is a problem that can be identified in some men as distinct from the changes associated with aging or chronic disease. These men have mild hypogonadism and a clinical picture that is well within the scope of urologists to identify and manage. Andropause is neither life threatening nor trivial and there are clinical guidelines published that will help to refine the understanding and definition of this condition. The character of andropause is distinct from profound hypogonadism in its relation to age, the scope and degree of contributing symptoms and the marginal reduction in testosterone.… More >

Laurence H. Klotz¹, Yves Fradet²

Canadian Journal of Urology, Vol.9, Suppl.1, pp. 30-35, 2002

Abstract This consensus statement emerged from the 2^nd Canadian Ura-Oncology Congress, held January 16-20, 2002. The attendees at this meeting comprised approximately 125 urologists from across Canada, representing both community and academic perspectives. The group heard presentations by experts in the field addressing the spectrum of controversies in prostate cancer. After each session, the meeting broke into workshop sessions where attendees discussed the controversies raised by the speakers. Present in each workshop was a reporter who summarized the consensus of the group. These summaries were collected and integrated into a set of questions. At the end of More >

Tom Pickles¹, Andy Coldman², Norm Phillips³

Canadian Journal of Urology, Vol.9, No.3, pp. 1551-1557, 2002

Abstract Objective: To evaluate changes of prostate cancer incidence, referrals, stage, treatment and outcomes delivered in British Columbia since the 1980's.
Materials and methods: Examination of the BC Provincial Tumour Registry, BC Cancer Agency (BCCA) and BC Medical Services Plan databases.
Results: The number of incident cases increased linearly from 1980 through 1990. Between 1991 and 1995 a harvesting effect was seen due to unofficial PSA screening, balanced by a post-harvest effect between 1995 and 1998. Since 1999 the incidence has resumed the linear trend extrapolated from the 1980's. The age-standardised incidence rate has recently risen in younger (<65yrs)… More >

Richard Choo¹, Howard Sandler², Padraig Warde³, George Hruby¹, Gerrit DeBoer¹

Canadian Journal of Urology, Vol.9, No.2, pp. 1479-1485, 2002

Abstract Objective: To evaluate practice patterns of the management of stage I seminoma of testis in Canada and a selected group in the United States.
Materials and methods: Survey among radiation oncologists treating genitourinary (GU) tumors in Canada and the RTOG GU committee members in the United States between January and March 2001.
Results: Response rate was 78% (73/93) in Canada and 67% (24/36) in the United States. Eighty-four percent described their clinical practice as a university affiliated teaching center, and 16% as community-based or private practice. Sixty-two percent, 31% and 7% would manage 1-5, 6-10 and ≥11 cases… More >